OMAHA, Neb. (July 15, 2020)—The third annual MidWest Drug Development Conference has been postponed due to circumstances related to the COVID-19 pandemic.

“We hated to do it, and that’s why we put off the decision as long as we did,” said Matt Boehm, Ph.D., the event organizer and director of licensing at UNeMed. “Even though we’re still more than two months out, we’d rather err on the side of caution.”

UNeMed is the conference’s primary organizer and sponsor and the technology transfer office for all Omaha campuses of the University of Nebraska.

In addition to obvious concerns for the health of attendees and staffers, general uncertainty related to travel and hosting large events also played a large role in the decision to postpone the event.

The value of the conference was in combining assets of leading Midwest universities into one event that served as a one-stop shop for major pharmaceutical and investment firms to find new treatments and cures hidden in so-called “flyover country.”

While the conference will not happen in 2020, organizers will start planning for the conference to take place again in 2021. Any updates will first be announced via the MidWest Drug Development Conference newsletter, which can subscribed to at